Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.
Subramani E, Radoul M, Najac C, Batsios G, Molloy AR, Hong D, Gillespie AM, Santos RD, Viswanath P, Costello JF, Pieper RO, Ronen SM.
Subramani E, et al. Among authors: molloy ar.
Cancer Res. 2020 Nov 15;80(22):5098-5108. doi: 10.1158/0008-5472.CAN-20-1314. Epub 2020 Sep 21.
Cancer Res. 2020.
PMID: 32958546
Free PMC article.